Clinical Value of EMR3 in Sepsis Diagnosis, Monitoring, and Prognosis: A Multicenter Prospective Observational Study | MicrobiomeTrials← Back to trialsNCT07896018
Clinical Value of EMR3 in Sepsis Diagnosis, Monitoring, and Prognosis: A Multicenter Prospective Observational Study
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-11Est. Completion: 2027-06
Enrollment target: 3,000 participants Other microbiome trials you might be interested in
Neonatal Respiratory Distress Related ConditionsMeconiumPerinatal MorbidityNeonatal AcidosisCord BloodNeonatal Brain InjuryMaternal MorbidityMechanical VentilationCPAPSurfactantPerinatal DeathAmnioinfusionNICU Admission
Meconium in the amniotic fluid occurs in about one out of seven pregnancies and increases the chance that a newborn may …
Milwaukee, United StatesEst. completion Apr 15, 2029
Recruiting
Very Preterm InfantNecrotizing Enterocolitis (NEC)
The goal of this clinical trial is to evaluate whether supplementing with pasteurized donor human milk (pHDM) or preterm…
Guilin, ChinaEst. completion Jul 31, 2028
Septic ShockSepsisHypovolemia
This study is being conducted to evaluate the safety and effectiveness of VBI-S in elevating the blood pressure of septi…
Chandler, United StatesCompleted Jun 29, 2026